First Wave BioPharma

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FWBI and other ETFs, options, and stocks.

About FWBI

First Wave Biopharma, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of non-systemic therapies for the treatment of gastrointestinal diseases. The firm is involved in a therapeutic development pipeline populated with multiple clinical stage programs built around its proprietary technologies, such as Niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic Adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients. 

CEO
James E. Sapirstein
CEOJames E. Sapirstein
Employees
17
Employees17
Headquarters
Boca Raton, Florida
HeadquartersBoca Raton, Florida
Founded
2014
Founded2014
Employees
17
Employees17

FWBI Key Statistics

Market cap
2.25M
Market cap2.25M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
599.25K
Average volume599.25K
High today
$1.72
High today$1.72
Low today
$1.40
Low today$1.40
Open price
$1.40
Open price$1.40
Volume
336.31K
Volume336.31K
52 Week high
$106.50
52 Week high$106.50
52 Week low
$1.19
52 Week low$1.19

FWBI Earnings

-$98.10
-$63.70
-$29.30
$5.10
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 14, Pre-Market
ActualExpected Nov 14, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.